← Open Payments lookup

MICHELLE SIMMONS: Open Payments

NPI 1306215660 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$874 in 20 payments from 10 companies in 2025. Trend: 2023 $1,816 · 2024 $1,815 · 2025 $874

Food & beverage: $874
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.1$135
GENZYME CORPORATION1$122
Grifols USA, LLC1$116
Bayer Healthcare Pharmaceuticals Inc.1$115
VERTEX PHARMACEUTICALS INCORPORATED5$113
Averitas Pharma Inc.3$87
ABBVIE INC.3$62
SPR Therapeutics, Inc2$55
Medtronic, Inc.2$41
Boston Scientific Corporation1$29

Products named: AUSTEDO XR, FABRAZYME, Prolastin-C Liquid, JOURNAVX, QUTENZA, BOTOX, SPRINT PNS System, Intracept.

Industry payments across TX — which companies pay providers there.